Appili Therapeutics: Funding, Investors & Team (Sep 2026)
Appili Therapeutics is an anti-infective pharmaceutical development company. Our approach lies in matching unmet medical needs with opportunities for more effective solutions that range from improvements in established therapies to entirely new classes of anti-infectives.
Appili Therapeutics has raised $1.5M across 2 funding rounds on record, the most recent an undisclosed round of $530k announced in Nov 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Appili Therapeutics Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Appili Therapeutics Funding Rounds
Appili Therapeutics raised $1.0M in a Post-IPO Equity announced in Sep 2021.
4.2 years later, an undisclosed round of $530k was announced in Nov 2025.
Appili Therapeutics Founders and Leadership Team
Contact details for the Appili Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Appili Therapeutics Funding Compared to Other Biotechnology Startups
Appili Therapeutics' latest round of $530k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Appili Therapeutics in Biotechnology and Halifax
Companies Similar to Appili Therapeutics
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Appili Therapeutics Funding FAQs
What does Appili Therapeutics do?
Appili Therapeutics is an anti-infective pharmaceutical development company. Our approach lies in matching unmet medical needs with opportunities for more effective solutions that range from improvements in established therapies to entirely new classes of anti-infectives.
How much funding has Appili Therapeutics raised?
Appili Therapeutics has raised $1.5M across 2 rounds on record. The most recent is an undisclosed round of $530k announced in Nov 2025.
When did Appili Therapeutics last raise funding?
Appili Therapeutics' most recent funding round on record is an undisclosed round of $530k, announced in Nov 2025.
Who is the CEO of Appili Therapeutics?
Armand Balboni is listed as CEO at Appili Therapeutics.
Where is Appili Therapeutics headquartered?
Appili Therapeutics is based in Halifax, Nova Scotia, Canada.
How many employees does Appili Therapeutics have?
Appili Therapeutics is in the 11-50 employee band.
How does Appili Therapeutics' funding compare to other Biotechnology startups?
Appili Therapeutics' latest round of $530k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Appili Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Appili Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.